Mirion Technologies, Inc., in an amended filing of Form S-1 with the regulator, disclosed that it plans to offer 7.80 million shares of common stock out of the 11 million shares to be offered in its initial public offering. The remaining 3.2 million shares will be sold by the selling stockholders.
San Ramon, California-based Mirion is a provider of radiation detection, measurement, analysis and monitoring products and services to the nuclear, defense and medical end markets. Mirion filed its $100 million IPO plan in August 2009.
Mirion has applied to list its common stock for quotation on the NASDAQ Global Market under the symbol "MION"
Mirion now expects proposed maximum aggregate offering price to be $202.4 million. The underwriters have an option to buy up to 1.65 million additional shares from the selling stockholders.
Mirion said it estimates net proceeds to company from this offering, after deducting underwriting discounts and estimated offering expenses, to be approximately $106.7 million, assuming the shares are offered at $16 each, the midpoint of the price range.
For the six months ended December 2009, Mirion reported net loss allocable to common stockholders of $6.14 million and revenue of $108.66 million.
Stockholder American Capital, Ltd. (ACAS) and affiliated entities will beneficially own 49.3% of common stock after the offering, without over-allotment.
For comments and feedback: editorial@rttnews.com